RecruitingNot ApplicableNCT07789041

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

PuraStat for Aquablation Day Case (Use of PuraStat Following an Aquablation Procedure)

Sponsor

Endeavor Health

Enrollment

50 participants

Start Date

Aug 12, 2025

Study Type

INTERVENTIONAL

Conditions

BPH (Benign Prostatic Hyperplasia)BPH With Symptomatic Lower Urinary Tract Symptoms

Summary

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called PuraStat hydrogel and the syringe for people with bph (benign prostatic hyperplasia) and bph with symptomatic lower urinary tract symptoms. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPuraStat hydrogel and the syringe

PuraStat device is FDA-approved for other uses, such as gastrointestinal endoscopy and ENT (ear, nose, throat) procedures. Its use in this study for urology is investigational.

Locations(1)

Glenbrook Hospital- Endeavor Health

Glenview, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07789041

Related Trials

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

NCT07538622

Transurethral Thermodilatation vs. Prostatic Urethral Lift for Moderate-to-Severe BPH

NCT07759752

Sonablate HIFU International Registry for PC & BPH Patients

NCT07757490

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT07741656

A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia

NCT075837061 location